Apellis Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of various diseases, including geographic atrophy (GA) and other retinal diseases. The company is focused on delivering life-changing treatments for patients with serious diseases.

apellis.com

Biopharma

Therapeutics

Pharmaceutical

Apellis Pharmaceuticals, Inc. announced it raised $20 Million in an initial filing from an offering of $60.1 Million

Company Information

Related People

Funding Insights

Apellis Pharmaceuticals, Inc. announced it raised $20 Million in an initial filing from an offering of $60.1 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information